Rubfila International Limited (RUBFILA)
₹64.11 -2.85% last close, 16 Oct
Latest quarterly results (Q1 FY27)
In its latest reported quarter, Q1 FY27, Rubfila International's revenue was ₹110 Cr (-24.0% year on year, -31.4% on the previous quarter), and net profit ₹6.0 Cr (-10.4% year on year); the operating margin was 8.3%.
| Q1 FY27 (₹ Cr) | Value | YoY vs Q1 FY26 | QoQ |
|---|---|---|---|
| Revenue | ₹110 | -24.0% | -31.4% |
| Operating profit | ₹9.1 | -10.9% | -17.3% |
| Net profit | ₹6.0 | -10.4% | -6.6% |
| EPS (₹) | 1.11 | -9.8% | -5.9% |
| Operating margin | 8.3% | — | — |
RUBFILA delivery percentage
NSE end-of-day data for
On Fri, 16 Oct 2026, 24.71% of the RUBFILA shares traded on NSE were taken to delivery, against the stock's own 20-session average of 51.54%. That is lower than usual for this stock. Turnover was only ₹20 lakh, so a handful of trades can move this figure.
Delivery in the last 5 sessions: 55.8% · 65.1% · 22.2% · 70.0% · 24.7%
A description of what the exchange published, not a recommendation. Names such as "accumulation" or "long buildup" label a pattern in the numbers. How delivery is analysed
📢 Recent Corporate Announcements
Rubfila International Limited has submitted its quarterly compliance certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026. The certificate, issued by Registrar and Share Transfer Agent Integrated Registry Management Services Private Limited on October 3, 2026, confirms the due dematerialisation and cancellation of share certificates within the mandated 15-day timeline. This is a standard quarterly administrative filing with no impact on business operations or financials.
- Compliance certificate submitted under Regulation 74(5) of SEBI Regulations, 2018 for the quarter ended September 30, 2026
- RTA Integrated Registry Management Services issued the certificate dated October 3, 2026
- Security certificates received for dematerialisation confirmed processed and substituted within 15 days
- Filing submitted to BSE (Scrip Code 500367) and NSE on October 10, 2026
Rubfila International has disclosed its 33rd AGM voting results, where shareholders decisively rejected the special resolution to ratify the divestment of its entire shareholding in subsidiary Premier Tissues India Limited. Out of 43,47,722 non-interested votes cast on the divestment resolution, 68.01% (29,56,734 votes) voted against, causing the proposal to fail. Meanwhile, ordinary resolutions including the adoption of FY26 financials and a final dividend of Rs 2.00 per share (40%) were approved with over 99.99% majority. The rejection halts the planned exit from the tissue business, which contributed Rs 46.05 Cr to H1 FY26 revenue.
- Special resolution to ratify the divestment of Premier Tissues India Ltd was defeated with 68.01% dissenting votes.
- Only 31.99% (13,90,988 votes) of non-interested voting shares supported the divestment resolution.
- Shareholders approved a final dividend of Rs 2.00 per equity share of Rs 5 face value (40%).
- Adoption of FY26 Standalone and Consolidated Financial Statements passed with 99.9976% assent.
- Re-appointment of Director Mr. Hardik B Patel approved with 99.9972% votes in favour.
Rubfila International has received a request from promoter Mrs. Bharati B Dattani to reclassify her holding of 6,95,091 equity shares from the 'Promoter' category to the 'Public' category. The shares represent 1.28% of the company's paid-up equity share capital. With total promoter holding standing at 58.27%, this proposed shift represents a minor administrative adjustment under SEBI Regulation 31A. The reclassification will be subject to board, shareholder, and stock exchange approvals.
- Received request dated 25-08-2026 from promoter Mrs. Bharati B Dattani
- Request covers 6,95,091 equity shares of the company
- Involved stake constitutes 1.28% of paid-up equity share capital
- Reclassification proposed from 'Promoter' to 'Public' category under SEBI Regulation 31A
Rubfila International has received a request from promoter Mrs. Bharati B Dattani to reclassify her holding of 6,95,091 equity shares from the 'Promoter' category to the 'Public' category. The shares represent 1.28% of the company's paid-up equity share capital. With total promoter holding standing at 58.27%, this proposed shift represents a minor administrative adjustment under SEBI Regulation 31A. The reclassification will be subject to board, shareholder, and stock exchange approvals.
- Received request dated 25-08-2026 from promoter Mrs. Bharati B Dattani
- Request covers 6,95,091 equity shares of the company
- Involved stake constitutes 1.28% of paid-up equity share capital
- Reclassification proposed from 'Promoter' to 'Public' category under SEBI Regulation 31A
Rubfila International concluded its 33rd Annual General Meeting on September 29, 2026, where shareholders considered ordinary and special resolutions. Crucially, special business included approval for the divestment of the company's entire shareholding in Premier Tissues India Limited, a subsidiary that contributed Rs 46.05 Cr in H1 FY26. Other items included adoption of FY26 financials and declaration of dividend. E-voting results under Regulation 44 will follow to confirm shareholder approval.
- AGM held on September 29, 2026, with 44 total shareholders present via video conference (1 promoter, 43 public).
- Special resolution proposed for the full divestment of Rubfila's shareholding in subsidiary Premier Tissues India Ltd.
- Remote e-voting was conducted from September 26, 2026 (9:00 AM) to September 28, 2026 (5:00 PM).
- Resolutions also included adoption of FY26 financial statements and declaration of dividend.
Rubfila International has fixed September 22, 2026, as the record date to determine shareholder eligibility for a final dividend of Rs 2 per equity share (face value Rs 5) for FY26. The dividend was originally recommended at the Board meeting held on May 26, 2026. At the current share price of Rs 63.6, the Rs 2 per share dividend represents a dividend yield of approximately 3.14%.
- Final dividend declared at Rs 2 per equity share of face value Rs 5 each
- Record date fixed for September 22, 2026
- Dividend recommended by the Board on May 26, 2026 for FY26
- Dividend yield stands at approximately 3.14% based on current market price of Rs 63.6
Rubfila International's Board of Directors has approved a request from promoter group member Mrs. Bharati Bharat Dattani to reclassify her shareholding to the public category. She holds 6,95,091 equity shares, representing approximately 1.28% of the company's paid-up equity share capital. The reclassification is subject to approval from stock exchanges (BSE and NSE) and company shareholders. The individual confirmed having no management role, board seat, or control over the company's affairs.
- Promoter group member Mrs. Bharati Bharat Dattani holds 6,95,091 equity shares representing ~1.28% of paid-up equity capital.
- Board approved initiating the reclassification process from 'Promoter and Promoter Group' to 'Public' category under Regulation 31A of SEBI LODR.
- Outgoing promoter confirmed holding zero management or board representation and no special rights.
- Board meeting commenced at 3:00 PM and concluded at 3:15 PM on September 11, 2026.
Rubfila International's Board has approved the complete divestment of its wholly owned subsidiary, Premier Tissues (India) Limited (PTIL), to Finquest Personal Care Pvt. Ltd. for an aggregate cash consideration of ₹61.00 crore. The transaction is a related-party deal, as the purchaser is associated with Rubfila's Chairman, Mr. Hardik Patel, who recused himself from deliberations. For FY26, PTIL contributed ₹95.74 crore (15.68%) to consolidated turnover and ₹51.49 crore (16.59%) to consolidated net worth. The deal consideration of ₹61.00 crore represents ~16.3% of Rubfila's current market cap (₹374 crore), allowing the company to refocus capital on its core rubber-thread business.
- 100% equity stake in subsidiary Premier Tissues (India) Ltd sold for ₹61.00 crore in cash
- PTIL accounted for ₹95.74 crore (15.68%) of FY26 consolidated revenue and ₹51.49 crore (16.59%) of net worth
- Transaction is a related-party deal with promoter-entity Finquest Personal Care Pvt. Ltd.
- Transaction documents to be executed by September 10, 2026, subject to shareholder approval at AGM on September 29, 2026
- Full consideration payable within 30 days of receiving requisite approvals on an 'as is where is' basis
Rubfila International has scheduled a Board Meeting for August 20, 2026, to finalize the 33rd Annual General Meeting (AGM) details. A key agenda item is the consideration of a valuation report for its wholly-owned subsidiary, Premier Tissues India Ltd. The trading window for the company's shares will be closed from August 14, 2026, until 48 hours after the meeting's conclusion. This valuation review indicates potential strategic corporate actions regarding the subsidiary.
- Board meeting scheduled for August 20, 2026, to approve AGM notice and reports.
- Agenda includes reviewing a valuation report for wholly-owned subsidiary Premier Tissues India Ltd.
- Trading window for company shares closed starting August 14, 2026.
- The meeting will convene the 33rd Annual General Meeting of the company.
Rubfila International has submitted its compliance certificate for the Structured Digital Database (SDD) for the quarter ended June 30, 2026, as required by SEBI (Prevention of Insider Trading) Regulations. The company confirmed that 4 specific events involving Unpublished Price Sensitive Information (UPSI) were identified during the quarter, and all 4 were successfully captured in the database. The filing indicates zero non-compliance and confirms that the database is non-tamperable with an 8-year record-keeping capacity. This is a routine procedural filing ensuring governance standards are met.
- 100% compliance achieved with 4 out of 4 required UPSI events captured in the database
- Zero non-compliance reported for the quarter ended June 30, 2026
- Database maintains a non-tamperable audit trail with a capability to store records for 8 years
- System captures the nature of UPSI along with specific date and time stamps for internal monitoring
Rubfila International reported a weak start to FY27 with consolidated revenue declining 7.9% YoY to ₹133.49 Cr. Net profit followed suit, dropping 13.3% YoY to ₹5.80 Cr, primarily due to a 12.8% decline in standalone revenue. A significant highlight is the auditor's qualified opinion regarding a ₹13.79 Cr 'Provision for Contingencies' accumulated over 11 years, which the auditors claim does not meet Ind AS 37 criteria for recognition. The tissue subsidiary, Premier Tissues, contributed ₹24.45 Cr to the topline but remains marginally loss-making at the PAT level.
- Consolidated Revenue from operations decreased 7.9% YoY to ₹133.49 Cr from ₹144.93 Cr.
- Consolidated Net Profit (PAT) declined 13.3% YoY to ₹5.80 Cr compared to ₹6.69 Cr in the previous year's quarter.
- Auditors issued a qualified conclusion regarding an unjustified ₹13.79 Cr provision for contingencies.
- Subsidiary Premier Tissues India Limited reported a net loss of ₹18.58 Lakhs on revenue of ₹24.45 Cr.
- Standalone revenue, representing the core rubber thread business, fell 12.8% YoY to ₹110.17 Cr.
Rubfila International Limited has announced the resignation of Mr. Bharat J Dattani, a Non-Executive Director, effective July 16, 2026. The resignation was tendered on July 15, 2026, and accepted by the Non-Executive Chairman the following day. This change in board composition occurs as the company manages a TTM revenue of Rs 603 Cr and a PAT of Rs 27 Cr. The filing is a routine regulatory disclosure and does not indicate any operational disruption.
- Mr. Bharat J Dattani (DIN 00608198) resigned as Non-Executive Director effective July 16, 2026
- The resignation letter was dated July 15, 2026, and accepted on July 16, 2026
- Company reported TTM revenue of Rs 603 Cr and TTM PAT of Rs 27 Cr
- Promoter holding remains stable at 58.27% as of March 2026
Rubfila International Limited has announced the resignation of Mr. Bharat J. Dattani from his position as a Non-Executive Director, effective July 16, 2026. The resignation was tendered on July 15, 2026, and accepted by the Chairman on July 16, 2026. This is a routine board-level change and does not involve executive management (MD/CEO). The company continues to operate with a TTM revenue of ‡603 Cr and maintains a debt-free balance sheet with a D/E ratio of 0.00.
- Resignation of Non-Executive Director effective July 16, 2026
- Director DIN 00608198 resigned from the board
- Company TTM revenue stands at ‡603 Cr
- Maintains zero debt status with D/E ratio of 0.00
Rubfila International has filed its quarterly compliance certificate under SEBI (Depositories and Participants) Regulations, 2018, for the period ending June 30, 2026. The document, issued by Integrated Registry Management Services, confirms that all share certificates received for dematerialization were processed, mutilated, and cancelled within the required 15-day window. This is a standard administrative procedure for listed entities to verify the accuracy of their share records with depositories. The filing has no impact on the company's financial health or business strategy.
- Confirmation of compliance for the quarter ended June 30, 2026
- Processing of dematerialization requests completed within 15 days
- Certificate issued by Integrated Registry Management Services on July 03, 2026
Rubfila International has announced the closure of its trading window for all designated persons starting July 1, 2026, in compliance with SEBI Insider Trading regulations. This closure is ahead of the declaration of the unaudited financial results for the quarter ended June 30, 2026. The window will remain closed until 48 hours after the results are officially disclosed to the exchanges. This is a standard administrative procedure and does not impact the company's operational fundamentals.
- Trading window closure begins on July 1, 2026
- Pertains to the unaudited financial statements for the quarter ended June 30, 2026
- Window to reopen 48 hours after the board meeting for results declaration
- Company reported TTM revenue of Rs 603 Cr and TTM PAT of Rs 27 Cr
Financial Performance
Revenue Growth by Segment
Consolidated revenue for Q2 FY26 reached INR 150.24 Cr, representing an 11.5% growth compared to INR 134.75 Cr in Q2 FY25. On a half-yearly basis (H1 FY26), revenue grew 17.3% to INR 295.17 Cr from INR 251.60 Cr in H1 FY25. The standalone segment contributed INR 128.21 Cr (85.3% of total) while the subsidiary Premier Tissues India Limited contributed approximately INR 22.03 Cr (14.7% of total) in Q2 FY26.
Geographic Revenue Split
Not specifically disclosed in the provided interim financial documents; however, the company operates out of Palakkad, Kerala, with a significant presence in the Indian domestic market and export capabilities for rubber thread products.
Profitability Margins
Net Profit Margin for Q2 FY26 stood at 5.24%, improving from 4.48% in Q2 FY25. Gross margins are heavily influenced by material costs which consumed 73.7% of revenue in Q2 FY26 compared to 74.8% in Q2 FY25, indicating a slight improvement in procurement efficiency or pricing power.
EBITDA Margin
EBITDA for Q2 FY26 was approximately INR 13.28 Cr (calculated as PBT of INR 10.51 Cr + Depreciation of INR 2.71 Cr + Finance Costs of INR 0.06 Cr), resulting in an EBITDA margin of 8.84%, up from 8.11% in the same quarter previous year.
Capital Expenditure
Consolidated purchase of property, plant, and equipment (CapEx) for H1 FY26 was INR 4.72 Cr. The company maintains a Capital Work-in-Progress (CWIP) of INR 0.41 Cr as of September 30, 2025.
Credit Rating & Borrowing
Finance costs remain exceptionally low at INR 0.06 Cr for Q2 FY26 (0.04% of revenue), suggesting a debt-free or very low-leverage capital structure. Total lease liabilities stand at INR 0.16 Cr.
Operational Drivers
Raw Materials
Natural Latex and chemicals used for heat-resistant latex rubber thread production, accounting for 73.7% of total revenue (INR 110.86 Cr in Q2 FY26).
Import Sources
Not specifically disclosed, but typically sourced from Kerala (domestic) and South East Asian countries (imports) for high-grade latex.
Capacity Expansion
Current fixed assets (Property, Plant, and Equipment) are valued at INR 166.29 Cr as of September 30, 2025, up from INR 163.16 Cr in March 2025, indicating ongoing maintenance and minor capacity debottlenecking.
Raw Material Costs
Raw material costs were INR 110.86 Cr in Q2 FY26, a 9.9% increase YoY in absolute terms, but decreased as a percentage of revenue from 74.8% to 73.7%, suggesting better cost management or higher realization per unit.
Manufacturing Efficiency
Employee benefit expenses were INR 10.97 Cr (7.3% of revenue), showing stability in labor productivity despite an 11.5% increase in production value.
Strategic Growth
Expected Growth Rate
17%
Growth Strategy
Growth is driven by the expansion of the subsidiary Premier Tissues India Limited, which contributed INR 46.05 Cr to H1 FY26 revenue. The company is focusing on increasing the utilization of its rubber thread capacity and leveraging its debt-free balance sheet (Net Worth of INR 297.86 Cr) to fund organic expansions and working capital requirements.
Products & Services
Heat-resistant latex rubber thread (HRLRT) used in apparel, furniture webbing, and medical applications; and tissue paper products (via Premier Tissues).
Brand Portfolio
RUBFILA, Premier Tissues.
New Products/Services
Expansion of the 'Premier' brand tissue portfolio into institutional and retail segments is expected to contribute 15-20% of consolidated revenue.
Market Expansion
The company is targeting increased export volumes for rubber threads to offset domestic competition and tap into higher-margin international markets.
Market Share & Ranking
Rubfila is one of India's largest manufacturers of heat-resistant latex rubber threads.
Strategic Alliances
Wholly-owned subsidiary: Premier Tissues India Limited.
External Factors
Industry Trends
The industry is shifting toward higher-grade, heat-resistant threads for premium apparel. The tissue paper industry is growing at 10-12% annually due to increased hygiene awareness, positioning the subsidiary for steady growth.
Competitive Landscape
Faces competition from large South East Asian manufacturers and smaller unorganized domestic players.
Competitive Moat
Cost leadership in the Indian market and a strong distribution network for the 'Premier' brand in the tissue segment. The debt-free status provides a significant competitive advantage in a capital-intensive industry.
Macro Economic Sensitivity
Highly sensitive to the textile and apparel industry cycle, which drives demand for rubber threads.
Consumer Behavior
Increasing demand for stretchable fabrics in athleisure and fast fashion is driving long-term demand for rubber threads.
Geopolitical Risks
Trade barriers or export incentives in competing nations like Thailand and Malaysia could impact Rubfila's export competitiveness.
Regulatory & Governance
Industry Regulations
Compliance with BIS standards for rubber threads and environmental norms for chemical usage in manufacturing.
Environmental Compliance
The company must comply with Kerala State Pollution Control Board norms regarding latex processing and effluent treatment.
Taxation Policy Impact
Effective tax rate for Q2 FY26 was 23.9% (INR 2.51 Cr tax on INR 10.51 Cr PBT).
Legal Contingencies
No major pending litigation with material financial impact disclosed in the limited review report.
Risk Analysis
Key Uncertainties
Volatility in natural rubber prices (73.7% cost exposure) and potential slowdown in the global apparel market.
Geographic Concentration Risk
Manufacturing is concentrated in Palakkad, Kerala, making it susceptible to regional labor or environmental disruptions.
Third Party Dependencies
High dependency on latex suppliers; however, the company maintains multiple sourcing channels.
Technology Obsolescence Risk
Low risk in the core rubber thread business, but requires continuous process optimization to maintain margins.
Credit & Counterparty Risk
Trade receivables stand at INR 72.06 Cr (approx. 43 days of sales), which is relatively high and requires monitoring for credit risk.
